Among them, CCL2 was continuously overexpressed, while the expression of other chemokines decreased significantly at the later stage both in residual CT26 and MC38 tumor (Fig. 6a, Supplementary Fig. 7a, b). This evidence concerns the gene DDX53 and neoplasm.